HiFiBiO Therapeutics Closes $67 Million Series C Financing to Build on Recent Success and Advance Pipeline of Novel Antibody Drugs for Cancer and Autoimmune Disorders
Latest funding led by IDG Capital with participation from Sequoia Capital China, Delian Capital, Hanne Capital, VI Ventures, Legend Star…